Keith became Chair of British Patient Capital in June 2018.
Keith led the planning and establishment of the British Business Bank from January 2013 and was appointed Chief Executive Officer in December 2013.
Prior to this, Keith was a Director at UK Financial Investments, joining in 2009 to manage the UK government’s shareholdings in Bradford & Bingley, Northern Rock and Northern Rock Asset Management. Keith joined UKFI from Banco Santander where he was a Director of Sovereign Bancorp in the US.
He was previously Director of Strategy and Planning at Abbey National and a member of the Executive Committee, and served as Chair of Santander’s Asset Management and Credit Card businesses in the UK. Before joining Abbey in 2004, Keith spent 18 years at LEK Consulting, where he was a partner specialising in financial services.
Catherine was appointed CEO of British Patient Capital in October 2018.
Catherine joined the British Business Bank in 2016 in the role of CEO of British Business Investments. She was previously Head of Private Equity at Cardano Risk Management, where she was responsible for managing a global portfolio of private capital investments on behalf of UK pension funds. Before this she was a Partner and Managing Director of Fondinvest Capital in Paris, investing on a primary and secondary basis in European private equity funds.
Prior to this Catherine was one of the Founders of Nordic fund of funds manager Proventure, which invested in venture and growth capital funds in Western Europe, before launching a consulting business advising investors in Europe, the US and Asia on European private capital strategies. Catherine began her career in London at Venture Economics before joining Private Equity firm Cinven as an investment manager.
Russ joined British Patient Capital as an independent Non-executive Director in June 2018.
Russ is the former Chief Executive Officer of Touchstone Innovations plc, one of the UK’s leading technology investment companies, championing outstanding science by commercialising innovative research from UK universities. Russ joined as Chief Investment Officer in 2006, then became CEO in 2013 through to the acquisition of Touchstone in 2017 by IP Group plc for £500m.
From 2003 to 2006 he was a Director at the growth equity and venture capital firm Scottish Equity Partners LLP. Prior to this he spent 16 years at the international venture capital and private equity company 3i Group plc, latterly as Director in its UK Technology Group.
Hazel joined British Patient Capital as an independent Non-executive Director in June 2019.
Hazel is the co-founder and Chair of FirstCapital, an investment bank which provides mergers and acquisitions, private equity and growth capital advice to high growth technology companies. She also currently chairs the Innovation Finance Sub-Committee for Innovate UK, the UK’s national innovation agency, having been a Governing Board member of Innovate UK until 2018. Hazel is a member of the Future Fifty advisory panel and was previously on the Investment Advisory Panel of the North West Fund.
Hazel was awarded an OBE in the 2017 New Years’ Honours list for services to entrepreneurship and innovation. She won the CBI/Real Business First Women in Finance award in 2016 and the Women in Private Equity Award for Best Corporate Finance Adviser in 2015.